Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Duration: February 1, 2019
to
present
General Issues: Budget/Appropriations , Health Issues , Medical/Disease Research/Clinical Labs , Insurance
Spending: about $190,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Defense - Dept of (DOD)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Nancy Fox Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ)
Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA)
Molly McDonnell LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance
Michael Merola Deputy CoS, Sen. Torricelli
Charla Penn LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Donna Mullins CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa
Chelsey Hickman CoS, Rep. Kay Granger; LA Sen. Larry Craig
CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on April 22.
Original Filing: 301573843.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on Jan. 19.
Original Filing: 301531563.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on Oct. 18, 2023.
Original Filing: 301504083.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $10,000. The report was filed on July 18, 2023.
Original Filing: 301479982.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on April 19, 2023.
Original Filing: 301456918.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on Jan. 19, 2023.
Original Filing: 301434385.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2022
In Q3, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $10,000. The report was filed on Oct. 19, 2022.
Original Filing: 301411242.xml
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2022
In Q2, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on July 19, 2022.
Original Filing: 301386519.xml
Lobbying Issues
Funding for ALS research in annual Defense, Agriculture, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Agriculture, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS; establishment and funding of ARPA-H, agriculture/FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense, Agriculture, and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2022
In Q1, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on April 19, 2022.
Original Filing: 301363299.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS; establishment and funding of ARPA-H
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on Jan. 20, 2022.
Original Filing: 301335664.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on Oct. 18, 2021.
Original Filing: 301302393.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS . The report was filed on July 19, 2021.
Original Filing: 301282625.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on April 19, 2021.
Original Filing: 301257980.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234387.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on Oct. 15, 2020.
Original Filing: 301210188.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills; legislation related to the FDA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on July 15, 2020.
Original Filing: 301188131.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on April 17, 2020.
Original Filing: 301169274.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108491.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065496.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $20,000. The report was filed on July 19, 2019.
Original Filing: 301050747.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, WINNING STRATEGIES WASHINGTON lobbied for I AM ALS , earning $10,000. The report was filed on April 16, 2019.
Original Filing: 301026449.xml
Lobbying Issues
Funding for ALS research in annual Defense and Labor HHS Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
SSDI legislation related to ALS patients
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
WINNING STRATEGIES WASHINGTON filed a lobbying registration on Feb. 21, 2019 to represent I AM ALS, effective Feb. 1, 2019.
Original Filing: 301020594.xml
Issue(s) they said they’d lobby about: secure funding and promote policies that support ALS research .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...